| Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial) | Propafenone | Not applicable | Not yet recruiting | Korea University Anam Hospital | Nov 16, 2026 |
| An Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent Asthma | Arformoterol, Formoterol | Phase 3 | Not yet recruiting | AstraZeneca | Nov 13, 2026 |
| Changes in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) | Arformoterol, Formoterol | — | Not yet recruiting | AstraZeneca | Nov 12, 2026 |
| A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure. | Timolol | Phase 2 | Recruiting | Tavo Biotherapeutics | Nov 3, 2026 |
| Efficacy of Propranolol in Traumatic Brain Injury Patients Admitted to the ICU: A Prospective, Randomized, Triple-Blind Study | Propranolol | Phase 3 | Recruiting | Fundació d'investigació Sanitària de les Illes Balears | Oct 27, 2026 |
| Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients | Indacaterol | Phase 2 | Recruiting | AeroRx Therapeutics Inc. | Oct 26, 2026 |
| Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer | Propranolol | Phase 1 | Recruiting | Second Xiangya Hospital of Central South University | Oct 21, 2026 |
| Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung Cancer | Propranolol | Phase 1 | Recruiting | Second Xiangya Hospital of Central South University | Oct 21, 2026 |
| Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation | Albuterol, Levosalbutamol | Not applicable | Recruiting | China National Center for Cardiovascular Diseases | Oct 16, 2026 |
| Cardiocentric Inotropic Optimization in Spinal Cord Injury | Dobutamine | Early phase 1 | Not yet recruiting | University of British Columbia | Oct 13, 2026 |
| Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma | Arformoterol, Formoterol, Salmeterol | Phase 3 | Not yet recruiting | Chiesi Farmaceutici S.p.A. | Oct 5, 2026 |
| Efficacy of Cognitive Behavioral Therapy at Vestibular Migraine | Propranolol | Not applicable | Not yet recruiting | Sohag University | Sep 30, 2026 |
| Esmolol Versus Dexmedetomidine for Opioid-sparing in Laparoscopic Gynecological Surgery | Esmolol | Not applicable | Recruiting | Vasiliki Samartzi | Sep 29, 2026 |
| Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients | Timolol | Phase 4 | Recruiting | Brett King | Sep 29, 2026 |
| Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer | Propranolol | Phase 2 | Not yet recruiting | University of Southern California | Sep 23, 2026 |
| Renal Oxygenation-Guided AKI Reduction Trial | Dobutamine | Not applicable | Not yet recruiting | Chinese PLA General Hospital | Sep 14, 2026 |
| Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol | Propranolol | Phase 3 | Not yet recruiting | University Hospital, Toulouse | Aug 28, 2026 |
| Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma | Arformoterol, Formoterol | Phase 3 | Recruiting | Lunan Better Pharmaceutical Co., LTD. | Aug 17, 2026 |
| Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock | Dobutamine | Not applicable | Not yet recruiting | Leipzig Heart Science gGmbH | Aug 13, 2026 |
| Preventive Role of Melatonin and Propranolol Administration in Pediatric Migraine | Propranolol | Not applicable | Enrolling by invitation | Nishtar Medical University | Aug 3, 2026 |
| Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma | Propranolol | Phase 1 / Phase 2 | Not yet recruiting | Ting Liu | Jul 27, 2026 |
| Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD) | Arformoterol, Formoterol, Albuterol, Levosalbutamol | Phase 4 | Not yet recruiting | University of Tennessee Graduate School of Medicine | Jul 23, 2026 |
| Clearance in Primary Ciliary Dyskinesia | Albuterol, Levosalbutamol | Not applicable | Not yet recruiting | University of North Carolina, Chapel Hill | Jul 13, 2026 |
| Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECH | Timolol | Phase 4 | Active, not recruiting | Tecnoquimicas | Jul 8, 2026 |
| BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg]) | Arformoterol, Formoterol | Phase 4 | Recruiting | Chiesi Farmaceutici S.p.A. | Jun 24, 2026 |
| Remifentanil vs Esmolol During Intubation for Cerebral Aneurysm Coil Embolization | Esmolol | Not applicable | Not yet recruiting | Fatih Sultan Mehmet Training and Research Hospital | Jun 22, 2026 |
| Effects of Esmolol on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock | Esmolol | Not applicable | Not yet recruiting | First Affiliated Hospital of Wannan Medical College | Jun 18, 2026 |
| Fasenra: An Asthma Study | Albuterol, Levosalbutamol | Phase 4 | Enrolling by invitation | Endeavor Health | Jun 17, 2026 |
| Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma | Timolol | Phase 3 | Not yet recruiting | Ache Laboratorios Farmaceuticos S.A. | Jun 1, 2026 |
| Estimation of the Prevalence of Microcirculatory Dysfunction in Uremic Cardiopathy Among Dialysis Patients | Dobutamine | Not applicable | Not yet recruiting | Centre Hospitalier Departemental Vendee | May 27, 2026 |
| Efficacy of Early Rhythm Control in AF With TR Patients | Propafenone, Sotalol | — | Recruiting | Samsung Medical Center | May 26, 2026 |
| Opioid-free Anesthesia and Postoperative Delirium | Esmolol | Phase 1 | Not yet recruiting | Qianfoshan Hospital | May 22, 2026 |
| An Exploratory Study on Triple Inhaler Therapy in Patients With Early Lung Function Impairment | Arformoterol, Formoterol | Not applicable | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | May 19, 2026 |
| The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis | Albuterol, Levosalbutamol | Early phase 1 | Not yet recruiting | King Abdullah University Hospital | May 15, 2026 |
| The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial | Timolol | Phase 2 | Not yet recruiting | Geisinger Clinic | May 13, 2026 |
| Bilevel Positive Airway Pressure (BPAP) for Severe Asthma | Albuterol, Levosalbutamol | Not applicable | Not yet recruiting | Columbia University | May 12, 2026 |
| Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes | Nebivolol | Not applicable | Enrolling by invitation | Enhanced Emirates Limited | May 6, 2026 |
| Psilocybin Administration With 5-HT1a Blockade | Pindolol | Early phase 1 | Recruiting | Johns Hopkins University | May 4, 2026 |
| Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists | Arformoterol, Formoterol | Phase 3 | Recruiting | Chiesi Farmaceutici S.p.A. | Apr 23, 2026 |
| The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission. | Nebivolol | Phase 4 | Recruiting | Ziekenhuis Oost-Limburg | Apr 7, 2026 |
| Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant | Timolol | Phase 3 | Recruiting | Glaukos Corporation | Mar 27, 2026 |
| Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery | Esmolol | — | Recruiting | Marmara University | Mar 23, 2026 |
| Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris | Timolol | Early phase 1 | Recruiting | Pham Ngoc Thach University of Medicine | Mar 16, 2026 |
| Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation | Propafenone, Sotalol | Not applicable | Recruiting | Samsung Medical Center | Mar 3, 2026 |
| Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes | Sotalol | Not applicable | Recruiting | Western Sydney Local Health District | Mar 3, 2026 |
| Artificial Intelligence Stress Echo (FINESSE) Project | Dobutamine | — | Active, not recruiting | Milton Keynes University Hospital NHS Foundation Trust | Feb 25, 2026 |
| Ventilation and Perfusion in Asthmatics | Albuterol, Levosalbutamol | Phase 4 | Recruiting | University of Miami | Feb 23, 2026 |
| The PROTECT-HIE Pilot Trial | Dobutamine | Phase 2 | Recruiting | University of Alberta | Feb 12, 2026 |
| MEdical Treatment in Idiopathic Ventricular Fibrillation Patients | Nadolol | Phase 4 | Recruiting | Bo Gregers Winkel | Feb 12, 2026 |
| Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation | Sotalol | Phase 4 | Recruiting | Universitaire Ziekenhuizen KU Leuven | Feb 12, 2026 |
| Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation | Salmeterol | Not applicable | Recruiting | Juan Carlos Cardet | Feb 9, 2026 |
| Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing | Timolol | Phase 2 | Not yet recruiting | University of California, Davis | Feb 3, 2026 |
| Effect of Intraoperative Salbutamol Administration on Mechanical Power and Respiratory Mechanics in Obese Patients Undergoing Laparoscopic Bariatric Surgery | Albuterol, Levosalbutamol | Not applicable | Not yet recruiting | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital | Jan 30, 2026 |
| Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot Study | Dobutamine | Not applicable | Recruiting | University Hospital Dubrava | Jan 14, 2026 |
| Immuno-inflammatory Response of Erdosteine in COPD | Vilanterol | Not applicable | Not yet recruiting | Pierachille Santus, MD, PhD | Jan 9, 2026 |
| POCUS-Guided Esmolol in Septic Shock: A Pilot RCT | Esmolol | Phase 1 / Phase 2 | Not yet recruiting | John Basmaji | Jan 2, 2026 |
| Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension | Dobutamine | — | Recruiting | Region Stockholm | Dec 26, 2025 |
| VENTURI (VENTilation Using Respiratory Imaging) | Vilanterol | Phase 2 | Recruiting | University of Alabama at Birmingham | Dec 15, 2025 |
| Dronedarone Rhythm Intervention for Early Atrial Fibrillation | Propafenone | Phase 4 | Not yet recruiting | Inha University Hospital | Dec 8, 2025 |
| Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients | Nebivolol | Phase 2 | Recruiting | Ain Shams University | Nov 18, 2025 |
| 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation | Vilanterol | Phase 4 | Recruiting | Western University, Canada | Sep 25, 2025 |
| Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram Trial | Nadolol | Not applicable | Recruiting | University of California, Los Angeles | Sep 11, 2025 |
| Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators | Vilanterol | Phase 4 | Recruiting | University of Tennessee Graduate School of Medicine | Aug 21, 2025 |
| Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure | Nebivolol | Not applicable | Not yet recruiting | Yonsei University | Aug 14, 2025 |
| Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion | Salmeterol | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | Aug 11, 2025 |
| A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) | Pindolol | Phase 2 | Recruiting | Actimed Therapeutics Ltd | Aug 3, 2025 |
| Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD | Indacaterol, Olodaterol, Salmeterol, Vilanterol | Not applicable | Active, not recruiting | Istanbul Medeniyet University | Jul 10, 2025 |
| Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy Patients | Dilevalol | Phase 4 | Enrolling by invitation | Ain Shams University | Jun 24, 2025 |
| Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intubation on an Outpatient Basis | Esmolol | Phase 4 | Recruiting | University Hospital, Limoges | Jun 13, 2025 |
| Effect of MGRNOX-Guided General Anesthesia on Opioid Consumption in Patients | Esmolol | Not applicable | Recruiting | Peking University Shenzhen Hospital | Jun 4, 2025 |
| Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED | Terbutaline | Phase 3 | Recruiting | University of Monastir | May 20, 2025 |
| Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT) | Nebivolol | — | Recruiting | A.Menarini Asia-Pacific Holdings Pte Ltd | Apr 22, 2025 |
| Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control | Propafenone, Sotalol | — | Not yet recruiting | Kansas City Heart Rhythm Research Foundation | Jan 20, 2025 |
| Nebivolol ANOCA Treatment Randomized Trial | Nebivolol | Phase 3 | Not yet recruiting | Spanish Society of Cardiology | Jan 1, 2025 |
| Clenbuterol to Target DUX4 in FSHD | Clenbuterol | Phase 1 | Recruiting | Jeffrey Statland | Dec 6, 2024 |
| Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation | Propafenone | Not applicable | Recruiting | Seoul National University Hospital | Nov 21, 2024 |
| Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma | Salmeterol | Phase 2 | Active, not recruiting | Sanofi | Nov 6, 2024 |
| Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies | Sotalol | Not applicable | Recruiting | IRCCS Ospedale San Raffaele | Nov 1, 2024 |
| Urinary Concentration After Salmeterol | Salmeterol | Not applicable | Recruiting | University of Copenhagen | Oct 24, 2024 |
| Salmeterol Effect on Exercise Performance | Salmeterol | Not applicable | Recruiting | University of Copenhagen | Oct 23, 2024 |
| Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability. | Salmeterol | Not applicable | Recruiting | University of Copenhagen | Oct 23, 2024 |
| Exercise as an Immune Adjuvant for Allogeneic Cell Therapies | Nadolol | Early phase 1 | Recruiting | University of Arizona | Oct 16, 2024 |
| Air Pollution and Inhaled Corticosteroids in COPD | Vilanterol | Phase 4 | Not yet recruiting | University of British Columbia | Aug 14, 2024 |
| The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life | Terbutaline | — | Recruiting | Wenjing Zhou | Aug 2, 2024 |
| Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction | Nebivolol | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | Jul 24, 2024 |
| Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. | Procaterol | Phase 3 | Active, not recruiting | AstraZeneca | Jun 25, 2024 |
| The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD | Vilanterol | Phase 3 | Recruiting | Mahidol University | Jun 25, 2024 |
| Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries | Nebivolol | Phase 2 / Phase 3 | Recruiting | Stanford University | May 22, 2024 |
| The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients | Tulobuterol | Phase 4 | Recruiting | SamA Pharmaceutical Co., Ltd | May 13, 2024 |
| Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma | Vilanterol | Phase 4 | Active, not recruiting | GlaxoSmithKline | Apr 18, 2024 |
| Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation | Sotalol | Not applicable | Recruiting | Nantes University Hospital | Mar 20, 2024 |
| A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy | Clenbuterol | Phase 2 | Recruiting | Gianni Soraru | Dec 13, 2023 |
| Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial) | Propafenone | Not applicable | Recruiting | The First Affiliated Hospital with Nanjing Medical University | Nov 9, 2023 |
| Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation | Propafenone, Sotalol | Not applicable | Active, not recruiting | Boston Scientific Corporation | Oct 23, 2023 |
| Role of Lung Function for Exercise Capacity in Well-trained Individuals | Indacaterol | Not applicable | Recruiting | Morten Hostrup, PhD | Oct 11, 2023 |
| U-LABA/ICS Effects on Exercise Performance, Indacaterol | Indacaterol | Not applicable | Recruiting | Morten Hostrup, PhD | Oct 4, 2023 |
| A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. | Indacaterol | Phase 3 | Recruiting | Novartis Pharmaceuticals | Mar 20, 2023 |
| A Preliminary Study for INFORMED | Nadolol, Penbutolol, Pindolol | Phase 4 | Recruiting | Weill Medical College of Cornell University | Oct 18, 2022 |
| A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma | Indacaterol | Phase 3 | Recruiting | Novartis Pharmaceuticals | Sep 30, 2022 |
| Safest Choice of Antihypertensive Regimen for Postpartum Hypertension | Dilevalol | Phase 3 | Recruiting | Loma Linda University | Sep 22, 2022 |
| Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome | Celiprolol | Phase 3 | Recruiting | Acer Therapeutics Inc. | Jun 27, 2022 |
| Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial | Dilevalol | Phase 4 | Recruiting | Nebraska Methodist Health System | Apr 4, 2022 |
| A 24-week rPMS Study in Real-world Setting for Enerzair | Indacaterol | — | Active, not recruiting | Novartis Pharmaceuticals | Mar 10, 2022 |
| A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® | Indacaterol | — | Active, not recruiting | Novartis Pharmaceuticals | Feb 1, 2022 |
| Hot Flashes and Neurovascular Function in Women | Terbutaline | Not applicable | Recruiting | Mayo Clinic | Jan 18, 2022 |
| Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma | Procaterol | Not applicable | Recruiting | Intech Biopharm Ltd. | Jun 3, 2021 |
| Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy | Dilevalol | — | Recruiting | Marshall University | Feb 16, 2021 |
| Preeclampsia Postpartum Antihypertensive Treatment | Dilevalol | Phase 3 | Active, not recruiting | Medical College of Wisconsin | Mar 6, 2020 |
| Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | Terbutaline | — | Recruiting | Duke University | Feb 20, 2020 |
| Secondhand Smoke Respiratory Health Study | Procaterol | Phase 4 | Active, not recruiting | University of California, San Francisco | Jun 13, 2016 |
| Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs | Procaterol | — | Recruiting | University of Florida | May 10, 2013 |